MK-7602

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

HealthyMalaria

Phase 1

A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)

CompletedNCT06294912

Merck Sharp & Dohme LLCMalaria

Start: 2024-04-18End: 2025-01-06Updated: 2025-01-13

A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)

CompletedNCT06797674

Merck Sharp & Dohme LLCHealthy

Start: 2025-02-10End: 2025-08-12Updated: 2025-08-22